Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02186704 · ClinicalTrials.gov registry record

Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)

A clinical trial of Atrial Fibrillation, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
450
Enrollment target
8
Study locations

NCT02186704 is a study of Atrial Fibrillation that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 450 participants, below the 2,995-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (85% lower). The trial reports 8 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02186704, a study of Atrial Fibrillation, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
450 participants
Enrollment target
8
Study locations

Study Summary

The primary aim of the "Sensing Atrial High Rate Episodes with DX System in Implantable Cardioverter Defibrillators Trial" (SENSE Trial) is to assess the efficacy of a implantable cardioverter-defibrillator (ICD) lead with dedicated atrial sensing dipoles in detecting atrial high rate episodes. The study hypothesis is that an ICD system with a lead with dedicated atrial sensing dipoles will have a diagnostic yield comparable to that of a standard dual chamber ICD system and superior to that of a standard single chamber ICD system.

Conditions Studied

Atrial Fibrillation

Interventions

  • DEVICE ICD with DX system

Study Locations (8)

New York

  • Weill Cornell Medical College - New York
  • Westchester Medical Center - Valhalla

Ohio

  • The Ohio State Wexner University Medical Center - Columbus
  • Promedica Heart and Vascular Institute - Toledo

Alabama

  • University of Alabama at Birmingham - Birmingham

Massachusetts

  • Massachusetts General Hospital - Boston

Pennsylvania

  • Einstein Medical Center - Philadelphia

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2014-07
Est. Completion 2018-07

Sponsor

Weill Medical College of Cornell University

701 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02186704

The ClinicalTrials.gov registry entry for NCT02186704 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,995-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (85% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which ICD with DX system is the first listed.

NCT02186704 reports 8 study locations spanning 6 distinct geographic areas - top geographies include New York, Ohio, Alabama.

Frequently Asked Questions

What is clinical trial NCT02186704 about?

NCT02186704 is a clinical study titled "Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)". The primary aim of the "Sensing Atrial High Rate Episodes with DX System in Implantable Cardioverter Defibrillators Trial" (SENSE Trial) is to assess the efficacy of a implantable cardioverter-defibrillator (ICD) lead with dedicated atrial sensing dipoles in detecting atrial high rate episodes. The...

What is the current status of trial NCT02186704?

This trial is currently completed. The enrollment target is 450 participants. The study started on 2014-07. Estimated completion is 2018-07.

What conditions does trial NCT02186704 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT02186704?

The interventions under investigation include: ICD with DX system (DEVICE).

Who is sponsoring clinical trial NCT02186704?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02186704 being conducted?

This trial has 8 study locations across Alabama, Massachusetts, New York, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.